Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/25113306/ below:

US lung cancer trends by histologic type

Affiliations

• ¹ Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.

• PMID: 25113306
• PMCID: PMC4187244
• DOI: 10.1002/cncr.28749

Item in Clipboard

Denise Riedel Lewis et al. Cancer. 2014.

• ¹ Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.

• PMID: 25113306
• PMCID: PMC4187244
• DOI: 10.1002/cncr.28749

Item in Clipboard

Background: Lung cancer incidence rates overall are declining in the United States. This study investigated the trends by histologic type and demographic characteristics.

Methods: Surveillance, Epidemiology, and End Results (SEER) program rates of microscopically confirmed lung cancer overall and squamous cell, small cell, adenocarcinoma, large cell, other, and unspecified carcinomas among US whites and blacks diagnosed from 1977 to 2010 and white non-Hispanics, Asian/Pacific Islanders, and white Hispanics diagnosed from 1992 to 2010 were analyzed by sex and age.

Results: Squamous and small cell carcinoma rates declined since the 1990s, although less rapidly among females than males. Adenocarcinoma rates decreased among males and only through 2005, after which they then rose during 2006 to 2010 among every racial/ethnic/sex group; rates for unspecified type declined. Male/female rate ratios declined among whites and blacks more than among other groups. Recent rates among young females were higher than among males for adenocarcinoma among all racial/ethnic groups and for other specified carcinomas among whites.

Conclusions: US lung cancer trends vary by sex, histologic type, racial/ethnic group, and age, reflecting historical cigarette smoking rates, duration, cessation, cigarette composition, and exposure to other carcinogens. Substantial excesses among males have diminished and higher rates of adenocarcinoma among young females have emerged as rates among males declined more rapidly. The recognition of EGFR mutation and ALK rearrangements that occur primarily in adenocarcinomas are the primary basis for the molecular revolution that has transformed lung cancer diagnosis and treatment over the past decade, and these changes have affected recent type-specific trends.

Keywords: cigarette smoking; epidemiology; ethnicity; gender; histology; lung cancer incidence; race; trends.

© 2014 American Cancer Society.

PubMed Disclaimer

Trends in lung cancer incidence…

Trends in lung cancer incidence rates (age-adjusted 2000 US standard) from 1977 to…

Trends in lung cancer incidence rates (age-adjusted 2000 US standard) from 1977 to 1981 through 2006 to 2010 in the SEER 9 registries by histologic type.

Trends in lung cancer incidence…

Trends in lung cancer incidence rates (age-adjusted 2000 US standard) by histologic type…

Trends in lung cancer incidence rates (age-adjusted 2000 US standard) by histologic type and sex in the SEER 9 registries from 1977 to 1981 through 2006 to 2010 among whites and blacks, and in the SEER 13 registries 1992 to 1996 through 2006 to 2010 among whites (non-Hispanic), Asian/Pacific Islanders, and Hispanics (white).

Trends in age-specific lung cancer…

Trends in age-specific lung cancer incidence rates (age-adjusted 2000 US standard) by histologic…

Trends in age-specific lung cancer incidence rates (age-adjusted 2000 US standard) by histologic type and sex in the SEER 9 registries from 1977 to 1981 through 1987 to 1991 among whites and blacks, and in the SEER 13 registries from 1992 to 1996 through 2006 to 2010 among whites (non-Hispanic), blacks, Asian/Pacific Islanders, and Hispanics (white) by year of birth. Rates based on <16 cases are not shown.

Cigarette smoking by race/ethnicity and…

Cigarette smoking by race/ethnicity and sex: age-specific prevalence of ever-smoking by year of…

Cigarette smoking by race/ethnicity and sex: age-specific prevalence of ever-smoking by year of birth, age-adjusted prevalence of current smoking by year of survey, and age-specific prevalence of current smoking by year of birth [14,15].

• Reply to US lung cancer trends by histologic type.

  Lewis DR, Travis WD, Devesa SS. Lewis DR, et al. Cancer. 2015 Apr 1;121(7):1152-3. doi: 10.1002/cncr.29179. Epub 2014 Dec 2. Cancer. 2015. PMID: 25470011 No abstract available.

• US lung cancer trends by histologic type.

  Patel MI, Cheng I, Gomez SL. Patel MI, et al. Cancer. 2015 Apr 1;121(7):1150-2. doi: 10.1002/cncr.29180. Epub 2014 Dec 2. Cancer. 2015. PMID: 25470142 Free PMC article. No abstract available.

• Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010.

  Meza R, Meernik C, Jeon J, Cote ML. Meza R, et al. PLoS One. 2015 Mar 30;10(3):e0121323. doi: 10.1371/journal.pone.0121323. eCollection 2015. PLoS One. 2015. PMID: 25822850 Free PMC article.

• Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type.

  Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS. Jemal A, et al. Int J Cancer. 2003 May 20;105(1):101-7. doi: 10.1002/ijc.11020. Int J Cancer. 2003. PMID: 12672038

• United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.

  Travis WD, Lubin J, Ries L, Devesa S. Travis WD, et al. Cancer. 1996 Jun 15;77(12):2464-70. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2464::AID-CNCR8>3.0.CO;2-M. Cancer. 1996. PMID: 8640694

• Epidemiology of lung cancer.

  Osann KE. Osann KE. Curr Opin Pulm Med. 1998 Jul;4(4):198-204. doi: 10.1097/00063198-199807000-00002. Curr Opin Pulm Med. 1998. PMID: 10813232 Review.

• Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data.

  Ries LA. Ries LA. Semin Surg Oncol. 1994 Jan-Feb;10(1):21-30. doi: 10.1002/ssu.2980100106. Semin Surg Oncol. 1994. PMID: 8115783 Review.

• Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma.

  Feng C, Wu J, Yang F, Qiu M, Hu S, Guo S, Wu J, Ying X, Wang J. Feng C, et al. Oncol Lett. 2018 May;15(5):6925-6930. doi: 10.3892/ol.2018.8198. Epub 2018 Mar 7. Oncol Lett. 2018. PMID: 29725421 Free PMC article.

• Body mass index and lung cancer risk: a pooled analysis based on nested case-control studies from four cohort studies.

  Sanikini H, Yuan JM, Butler LM, Koh WP, Gao YT, Steffen A, Johansson M, Vineis P, Goodman GE, Barnett MJ, Hung RJ, Chen C, Stücker I. Sanikini H, et al. BMC Cancer. 2018 Feb 23;18(1):220. doi: 10.1186/s12885-018-4124-0. BMC Cancer. 2018. PMID: 29471809 Free PMC article.

• Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer.

  Kapadia NS, Valle LF, George JA, Jagsi R, D'Amico TA, Dexter EU, Vigneau FD, Kong FM. Kapadia NS, et al. Ann Thorac Surg. 2017 Dec;104(6):1881-1888. doi: 10.1016/j.athoracsur.2017.06.065. Epub 2017 Oct 26. Ann Thorac Surg. 2017. PMID: 29106887 Free PMC article.

• Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups.

  DeRouen MC, Thompson CA, Canchola AJ, Jin A, Nie S, Wong C, Jain J, Lichtensztajn DY, Li Y, Allen L, Patel MI, Daida YG, Luft HS, Shariff-Marco S, Reynolds P, Wakelee HA, Liang SY, Waitzfelder BE, Cheng I, Gomez SL. DeRouen MC, et al. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1506-1516. doi: 10.1158/1055-9965.EPI-21-0019. Epub 2021 May 17. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34001502 Free PMC article.

• Sociodemographic Survival Disparities for Lung Cancer in the United States, 2000-2016.

  Brouwer AF, Engle JM, Jeon J, Meza R. Brouwer AF, et al. J Natl Cancer Inst. 2022 Nov 14;114(11):1492-1500. doi: 10.1093/jnci/djac144. J Natl Cancer Inst. 2022. PMID: 35866998 Free PMC article.

1. 1. Howlader N, Noone AM, Krapcho M, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: Apr, 2013. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site.
2. 1. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends declining for most histologic types among males, increasing among females. Cancer. 1996;77:2464–2470. - PubMed
3. 1. Jemal A, Travis WD, Tarone RE, et al. Lung cancer rates convergence in young men and women in the United States: Analysis by birth cohort and histologic type. Int J Cancer. 2003;105:101–107. - PubMed
4. 1. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117:294–299. - PubMed
5. 1. Spitz MR, Wu X, Wilkinson A, Wei Q. Cancer of the lung. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology & Prevention. 3. New York: Oxford University Press; 2006. pp. 638–658.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3